EPO and chronic kidney disease: They are approved for the treatment of anaemia associated with chronic renal failure, cancer, HIV infection and in the surgical setting, to reduce allogenic blood transfusion.29,41 EPO-α and EPO-β, both produced by Chinese hamster ovary cells, share the same amino acid sequence as endogenous EPO and have the same physiological effects.